Evolution of insulin patents and market exclusivities in the USA
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference11 articles.
1. IDF Diabetes Atlas,2014
2. Change in medical spending attributable to diabetes: national data from 1987 to 2011;Zhuo;Diabetes Care,2015
3. Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010;Lipska;JAMA,2014
4. Trends in Medicaid reimbursements for insulin from 1991 through 2014;Luo;JAMA Intern Med,2015
5. Why is there no generic insulin? Historical origins of a modern problem;Greene;N Engl J Med,2015
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Estimated Sustainable Cost-Based Prices for Diabetes Medicines;JAMA Network Open;2024-03-27
2. Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019;PLOS Medicine;2023-11-16
3. Argument analysis of the ethical claims made by the pharmaceutical industry regarding drug pricing;Bioethics Open Research;2023-07-31
4. Leading with the trailing edge: facilitating patient choice for insulin products;Journal of Law and the Biosciences;2023-07-01
5. Insulin products and patents in the USA in 2004, 2014, and 2020: a cross-sectional study;The Lancet Diabetes & Endocrinology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3